Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 04:00PM ET
2.81
Dollar change
-0.14
Percentage change
-4.75
%
Index- P/E- EPS (ttm)-0.60 Insider Own24.86% Shs Outstand295.16M Perf Week-6.33%
Market Cap790.59M Forward P/E- EPS next Y-0.57 Insider Trans0.00% Shs Float221.93M Perf Month-3.77%
Income-175.80M PEG- EPS next Q-0.13 Inst Own34.59% Short Float7.32% Perf Quarter4.85%
Sales32.96M P/S23.99 EPS this Y-15.13% Inst Trans-9.64% Short Ratio7.39 Perf Half Y-13.00%
Book/sh3.65 P/B0.77 EPS next Y3.35% ROA-12.10% Short Interest16.25M Perf Year-44.25%
Cash/sh2.37 P/C1.18 EPS next 5Y- ROE-15.55% 52W Range2.34 - 6.05 Perf YTD-50.79%
Dividend Est.- P/FCF- EPS past 5Y- ROI-15.36% 52W High-53.59% Beta0.41
Dividend TTM- Quick Ratio9.34 Sales past 5Y387.52% Gross Margin-179.73% 52W Low20.34% ATR (14)0.17
Dividend Ex-Date- Current Ratio9.34 EPS Y/Y TTM-33.92% Oper. Margin-934.58% RSI (14)47.50 Volatility6.66% 5.73%
Employees586 Debt/Eq0.07 Sales Y/Y TTM-34.59% Profit Margin-533.32% Recom1.22 Target Price12.29
Option/ShortYes / Yes LT Debt/Eq0.06 EPS Q/Q-75.40% Payout- Rel Volume1.46 Prev Close2.95
Sales Surprise-15.26% EPS Surprise-36.66% Sales Q/Q-1.39% EarningsNov 05 BMO Avg Volume2.20M Price2.81
SMA20-1.89% SMA500.96% SMA200-14.47% Trades Volume3,219,952 Change-4.75%
Date Action Analyst Rating Change Price Target Change
Aug-20-24Downgrade The Benchmark Company Buy → Hold
Feb-22-24Upgrade The Benchmark Company Hold → Buy $9
Dec-05-23Initiated KeyBanc Capital Markets Overweight $6
Nov-06-23Downgrade The Benchmark Company Buy → Hold
Oct-13-23Resumed Piper Sandler Overweight $20
Feb-28-23Initiated Cowen Outperform
Dec-15-22Initiated Goldman Buy $30
Nov-16-22Initiated Truist Buy $29
Dec-21-21Initiated The Benchmark Company Buy $27
Nov-19-21Initiated Piper Sandler Overweight $33
Nov-21-24 04:05PM
Nov-07-24 10:05AM
Nov-05-24 11:17AM
02:11AM
Nov-04-24 11:00PM
05:55PM Loading…
05:55PM
04:05PM
Nov-01-24 09:06AM
Oct-22-24 04:05PM
Oct-16-24 08:58AM
Oct-04-24 09:00AM
Sep-26-24 04:05PM
Sep-01-24 10:26PM
Aug-29-24 08:41PM
04:05PM
05:13AM Loading…
05:13AM
Aug-07-24 12:45AM
Aug-06-24 06:15PM
04:05PM
Aug-01-24 06:32AM
Jul-31-24 09:00AM
Jul-21-24 05:37AM
Jul-09-24 12:00PM
Jun-25-24 04:05PM
Jun-13-24 05:40AM
May-28-24 04:05PM
May-13-24 06:00AM
May-08-24 11:03AM
07:01AM
04:30AM
08:57PM Loading…
May-07-24 08:57PM
06:05PM
06:01PM
04:05PM
May-01-24 09:00AM
Apr-30-24 10:01AM
Apr-08-24 12:05PM
Apr-03-24 04:05PM
Mar-27-24 04:30PM
Mar-26-24 05:25PM
Mar-19-24 04:05PM
Mar-11-24 09:00AM
Mar-05-24 04:30PM
Feb-26-24 06:55AM
Feb-23-24 04:30PM
Feb-22-24 08:15PM
Feb-21-24 09:22AM
07:09AM
Feb-20-24 11:00PM
07:00PM
04:57PM
04:05PM
Jan-30-24 01:02PM
Jan-23-24 04:05PM
Jan-15-24 09:30AM
Jan-03-24 09:40AM
Dec-20-23 04:05PM
Dec-16-23 01:00PM
Dec-11-23 03:30PM
Nov-16-23 04:05PM
Nov-03-23 12:05PM
10:51AM
08:42AM
05:55AM
05:30AM
Nov-02-23 05:56PM
04:05PM
Nov-01-23 04:05PM
Oct-31-23 04:05PM
Oct-26-23 10:02AM
Oct-11-23 04:05PM
Sep-29-23 12:43PM
Sep-27-23 09:00AM
Sep-20-23 05:02PM
Sep-14-23 07:03PM
Sep-13-23 09:00AM
Aug-31-23 10:12PM
07:37AM
Aug-19-23 10:44AM
Aug-04-23 10:23AM
01:00AM
Aug-03-23 05:35PM
04:05PM
Jul-26-23 01:17PM
Jul-25-23 09:55AM
Jul-24-23 04:05PM
Jul-08-23 08:43PM
Jul-06-23 04:05PM
Jun-17-23 09:52AM
May-30-23 06:50AM
May-29-23 04:05PM
May-27-23 08:43AM
May-24-23 02:32PM
01:56PM
01:30PM
01:10PM
May-14-23 02:57PM
May-06-23 08:03AM
May-05-23 10:13AM
12:30AM
AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.